OptimizeRx Corporation (OPRX)

Market Cap	321.02M
Revenue (ttm)	104.75M
Net Income (ttm)	-9.87M
Shares Out	18.56M
EPS (ttm)	-0.54
PE Ratio	n/a
Forward PE	30.62
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,337,614
Open	16.25
Previous Close	12.84
Day's Range	14.31 - 18.22
52-Week Range	3.78 - 18.22
Beta	1.33
Analysts	Buy
Price Target	11.06 (-36.07%)
Earnings Date	Aug 7, 2025

About OPRX

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2006
• Employees: 129
• Stock Exchange: NASDAQ
• Ticker Symbol: OPRX
• Website: https://www.optimizerx.com

Financial Performance

In 2024, OptimizeRx's revenue was $92.13 million, an increase of 28.81% compared to the previous year's $71.52 million. Losses were -$20.11 million, 14.5% more than in 2023.

Analyst Summary

According to 8 analysts, the average rating for OPRX stock is "Buy." The 12-month stock price target is $11.06, which is a decrease of -36.07% from the latest price.

Price Target

$11.06

(-36.07% downside)

Analyst Consensus: Buy